Last C$1.44 CAD
Change Today -0.06 / -4.00%
Volume 72.9K
ONC On Other Exchanges
Symbol
Exchange
Toronto
NASDAQ CM
Frankfurt
As of 12:48 PM 09/2/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Bradley G. Thompson Ph.D.

Executive Chairman, Chief Executive Officer and President, Oncolytics Biotech Inc.
AgeTotal Calculated CompensationThis person is connected to 38 board members in 2 different organizations across 5 different industries.

See Board Relationships
--C$1,076,695
As of Fiscal Year 2013

Background*

Dr. Bradley G. Thompson, also known as Brad, Ph.D. has been an Executive Chairman, Chief Executive Officer and President of Oncolytics Biotech Inc. since April 1999. Dr. Thompson served as Chief Executive Officer of Iteration Energy Ltd. (formerly SYNSORB Biotech Incorporated) from May 1994 to February 1999. He served as an Scientific Advisor of Diamond International Group Inc. Prior to Iteration Energy, he was employed as the Head of Biotechnology at The Alberta Research ...

Read Full Background

Corporate Headquarters*

1167 Kensington Crescent NW
Calgary, Alberta T2N 1X7

Canada

Phone: 403-670-7377
Fax: 403-283-0858

Board Members Memberships*

Former Director
Former Director
Former Director
Chairman
1999-Present
Executive Chairman, Chief Executive Officer and President

Education*

BS
University Of Alberta
PhD
The University Of Western Ontario

Other Affiliations*

Annual Compensation*

SalaryC$530,000
Total Annual CompensationC$530,000

Stock Options*

All Other CompensationC$68,295
Total Number of Options3,304,320

Total Compensation*

Total Annual Cash CompensationC$810,295
Total Short Term CompensationC$530,000
Other Long Term CompensationC$68,295
Total Calculated CompensationC$1,076,695
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ONC:CN C$1.44 CAD -0.06

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ONCOLYTICS BIOTECH INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.